Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
Clinical trial NCT06067425 · TERMINATED
Trial details
- NCT number
- NCT06067425
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2025-02-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.